Meta Pixel

News and Announcements

Wimp 2 Warrior on track for FY19 revenue to exceed $3M

  • Published March 27, 2019 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Wimp 2 Warrior is pleased to announce the company is on track for FY19 revenue to exceed $3M and potentially reach as high as $4M. This compares very favourably with FY17 $380K and FY18 $1.3M with CAGR tracking in a range of 180% to 220%.

With over 50 gyms licensed across an established 8 country footprint, Wimp 2 Warrior has a large and well-qualified wait list for new gym licenses. The company has also successfully opened their US Head Office (San Francisco) last December with the appointment experienced sports media executive, Scott Viscomi, as the inaugural President of North America for Wimp 2 Warrior.

Wimp 2 Warriot is primed to leverage its market-leading position in martial arts and combat sports training to fast track North American growth where the consumer market is predicted to grow from $4.6B to $6B by 2023. Wimp 2 Warrior is also progressing well towards the delivery of exciting digital assets during the second half of the year which has significant revenue upside.

Wimp 2 Warrior continue to progress rapidly towards its mission to become a unifying consumer brand for training and participation in combat sports globally.  The gym assets in this sector are ripe for technology-led disruption and aggregation from a trusted consumer brand.  Having secured licenses with the most elite gym owners and coaches in combat sports, Wimp 2 Warrior is primed to capitalise on this opportunity.

Series A is 75% filled ($500K capacity remains from the $2M sought).

Capital Insights
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship

From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now